SCHEMBL14064280

SCHEMBL14064280

Cc1sc(-c2cccc(Cl)c2)nc1-c1c(OC(=O)C(C)(C)C)n(C)n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.42
▸ HRH3 Q9Y5N1 4/20 0.41
▸ TRPM8 Q7Z2W7 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.37
▸ TGFBR1 P36897 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ RARA P10276 2/20 0.34
▸ RARB P10826 2/20 0.34
▸ RARG P13631 2/20 0.34
▸ MAOB P27338 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14064281 0.82 KMT2A (0.47) KMT2AHRH3TRPM8ADORA3TGFBR1
SCHEMBL14064297 0.75 MAPT (0.39) KMT2AHRH3TRPM8NPC1POLB
SCHEMBL13710178 0.73 HRH3 (0.41) KMT2AHRH3TRPM8ADORA3NPC1
SCHEMBL13761051 0.72 HRH3 (0.40) KMT2AHRH3TRPM8ADORA3NPC1
SCHEMBL14064295 0.68 APEX1 (0.46) KMT2AHRH3TRPM8NPC1POLB
SCHEMBL31677663 0.65 ALOX5 (0.56) KMT2AHRH3TRPM8ADORA3NPC1
SCHEMBL2089024 0.64 KMT2A (0.64) KMT2AHRH3TRPM8ADORA3NPC1
SCHEMBL16592233 0.62 POLB (0.32) POLBCNR2
SCHEMBL14579498 0.62 HRH3 (0.45) KMT2AHRH3NPC1POLBRAB9A
SCHEMBL13710172 0.62 KMT2A (0.44) KMT2AHRH3TRPM8ADORA3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7420062-B2 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics BAYER CROPSCIENCE, AG (DE) 2008-09-02 — — US disclosed
US-7420062-B2 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics BAYER CROPSCIENCE, AG (DE) 2008-09-02 — — US disclosed
US-20070066488-A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-03-22 — — US disclosed
US-20070066488-A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066488-A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics DDT, CYP1A2, HPD KMT2A 2381/4885HRH3 511/4885TRPM8 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback